Literature DB >> 33210224

The spectrum of lupus myocarditis: from asymptomatic forms to cardiogenic shock.

Maya Guglin1, Carson Smith2, Roopa Rao2.   

Abstract

Lupus myocarditis is a serious, potentially deadly disease. When it presents as an acute or fulminant myocarditis in a patient without an established diagnosis of lupus, lupus as an etiology of the condition is not commonly suspected. Meanwhile, it has a distinct treatment which may be lifesaving. Review of the literature can shed more light as current management is mostly based on clinical experience and case reports rather than randomized control trials. In this review we are discussing this diagnostic entity, focusing on cardiogenic shock as a manifestation of lupus myocarditis, and discussing management including aggressive immunosuppression, mechanical circulatory support, and cardiac transplantation.

Entities:  

Keywords:  Cardiogenic shock; Lupus myocarditis; Systemic lupus erythematosus

Mesh:

Year:  2020        PMID: 33210224     DOI: 10.1007/s10741-020-10054-w

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  52 in total

1.  Lupus Myocarditis: Initial Presentation and Longterm Outcomes in a Multicentric Series of 29 Patients.

Authors:  Guillemette Thomas; Fleur Cohen Aubart; Laurent Chiche; Julien Haroche; Miguel Hié; Baptiste Hervier; Nathalie Costedoat-Chalumeau; Karine Mazodier; Mikael Ebbo; Philippe Cluzel; Nadège Cordel; David Ribes; Jean Chastre; Nicolas Schleinitz; Véronique Veit; Jean-Charles Piette; Jean-Robert Harlé; Alain Combes; Zahir Amoura
Journal:  J Rheumatol       Date:  2016-11-15       Impact factor: 4.666

2.  A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value.

Authors:  S Jacobsen; J Petersen; S Ullman; P Junker; A Voss; J M Rasmussen; U Tarp; L H Poulsen; G van Overeem Hansen; B Skaarup; T M Hansen; J Pødenphant; P Halberg
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

3.  Echocardiographic findings in systemic lupus erythematosus.

Authors:  N E Doherty; G Feldman; G Maurer; R J Siegel
Journal:  Am J Cardiol       Date:  1988-05-01       Impact factor: 2.778

4.  Child-onset systemic lupus erythematosus is associated with a higher incidence of myopericardial manifestations compared to adult-onset disease.

Authors:  J C Chang; R Xiao; L Mercer-Rosa; A M Knight; P F Weiss
Journal:  Lupus       Date:  2018-10-14       Impact factor: 2.911

5.  The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients.

Authors:  B H Bulkley; W C Roberts
Journal:  Am J Med       Date:  1975-02       Impact factor: 4.965

6.  Cardiac abnormalities in systemic lupus erythematosus: a prospective M-mode, cross-sectional and Doppler echocardiographic study.

Authors:  W H Leung; K L Wong; C P Lau; C K Wong; C H Cheng
Journal:  Int J Cardiol       Date:  1990-06       Impact factor: 4.164

7.  Heart disease in systemic lupus erythematosus: diagnosis and management.

Authors:  A Ansari; P H Larson
Journal:  Tex Heart Inst J       Date:  1985-03

8.  Clinical features and outcome of lupus myocarditis in the Western Cape, South Africa.

Authors:  R Du Toit; P G Herbst; A van Rensburg; L M du Plessis; H Reuter; A F Doubell
Journal:  Lupus       Date:  2016-05-25       Impact factor: 2.911

9.  Lupus myocarditis: a single center experience and a comparative analysis of observational cohort studies.

Authors:  J Tanwani; K Tselios; D D Gladman; J Su; M B Urowitz
Journal:  Lupus       Date:  2018-04-11       Impact factor: 2.911

10.  2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus.

Authors:  Martin Aringer; Karen Costenbader; David Daikh; Ralph Brinks; Marta Mosca; Rosalind Ramsey-Goldman; Josef S Smolen; David Wofsy; Dimitrios T Boumpas; Diane L Kamen; David Jayne; Ricard Cervera; Nathalie Costedoat-Chalumeau; Betty Diamond; Dafna D Gladman; Bevra Hahn; Falk Hiepe; Søren Jacobsen; Dinesh Khanna; Kirsten Lerstrøm; Elena Massarotti; Joseph McCune; Guillermo Ruiz-Irastorza; Jorge Sanchez-Guerrero; Matthias Schneider; Murray Urowitz; George Bertsias; Bimba F Hoyer; Nicolai Leuchten; Chiara Tani; Sara K Tedeschi; Zahi Touma; Gabriela Schmajuk; Branimir Anic; Florence Assan; Tak Mao Chan; Ann Elaine Clarke; Mary K Crow; László Czirják; Andrea Doria; Winfried Graninger; Bernadett Halda-Kiss; Sarfaraz Hasni; Peter M Izmirly; Michelle Jung; Gábor Kumánovics; Xavier Mariette; Ivan Padjen; José M Pego-Reigosa; Juanita Romero-Diaz; Íñigo Rúa-Figueroa Fernández; Raphaèle Seror; Georg H Stummvoll; Yoshiya Tanaka; Maria G Tektonidou; Carlos Vasconcelos; Edward M Vital; Daniel J Wallace; Sule Yavuz; Pier Luigi Meroni; Marvin J Fritzler; Ray Naden; Thomas Dörner; Sindhu R Johnson
Journal:  Arthritis Rheumatol       Date:  2019-08-06       Impact factor: 15.483

View more
  1 in total

1.  Immunomodulating Therapies in Acute Myocarditis and Recurrent/Acute Pericarditis.

Authors:  Enrico Ammirati; Emanuele Bizzi; Giacomo Veronese; Matthieu Groh; Caroline M Van de Heyning; Jukka Lehtonen; Marc Pineton de Chambrun; Alberto Cereda; Chiara Picchi; Lucia Trotta; Javid J Moslehi; Antonio Brucato
Journal:  Front Med (Lausanne)       Date:  2022-03-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.